MS
Morgan Stanley
$227.09
▲ 1.8%Updated Today 7:15 PM ET
▲ Up 68.4% over the last 12 months
Market Cap
$352.00B
P/E
19.42x
Forward P/E (est.)
15.12x
ROE
16.3%
Revenue Growth
12.3%
EPS Growth
28.4%
Profit Margin
14.6%
FCF Yield
3.7%
Debt / Equity
7.9x
ROIC
—
Interest Coverage
—
Current Ratio
—
Dividend Yield
1.8%
Implied Growth (rev. DCF)
—
Rating Score
57/100
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what MS's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. MS trades near $227.09, above its 50-day average ($198.16) and 200-day average ($175.55). Price above both averages, with the shorter one above the longer, is the textbook definition of an uptrend — momentum favours buyers.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 65 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. MS's is $6.37 (~2.8% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month MS found buyers near $196.90 (support) and sellers near $230.47 (resistance); its 52-week range is $129.93–$230.47. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 1.9× the 20-day average — heavier than usual, which adds conviction to the move. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
Morgan Stanley (MS) is a mega-cap company in the Investment Banking & Brokerage industry, part of the Financials sector of the S&P 500, with a market value around $352.00B.
In its latest reported year it generated about $34.27B in revenue.
Our model rates MS Neutral (57/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
4Y CAGR
2.4%
Revenue moved from $31.23B in 2010 to $34.27B in 2014, a 2.4% compound annual growth rate. The most recent year grew a steady 12.3% year over year. Consistent top-line growth is one sign of healthy demand.
Gross Margin
55.6%
Operating Margin
18.9%
Net Margin
14.6%
ROE
16.3%
Morgan Stanley keeps about 14.6% of each sales dollar as net profit, with a 55.6% gross margin and 18.9% operating margin. Return on equity is 16.3%. Margins are moderate — typical of a competitive but profitable business.
Total Debt
$363.01B
Net Debt
$229.48B
Net Debt / EBITDA
—
Debt / Equity
7.9x
Leverage: debt-to-equity is 7.9x. That is elevated leverage, which raises risk if earnings or rates move against it. It carries roughly $363.01B of total debt against $133.53B of cash.
Operating CF
—
Free Cash Flow
—
FCF Margin
—
P/E
19.42x
P/S
2.91x
P/B
2.55x
EV / EBITDA
—
MS trades at 19.4x trailing earnings (about 15.1x on estimated forward earnings), 2.9x sales, and 2.6x book value. That is a fairly typical valuation for a profitable company.
Where this stock sits versus what most companies trade at.
Typical ranges are general references (e.g., many stocks trade at ~18–26x earnings), not hard rules. Context only — not investment advice.
How MS stacks up against its Financials peers — valuation, profitability, and growth versus the sector median.
In the Financials sector (76 S&P 500 companies), MS ranks #53 of 76 by our overall rating. It trades at a premium versus the sector on earnings (19.4x P/E vs. 15.2x median) with a higher return on equity (16.3% vs. 15.3%) and faster revenue growth (12.3% vs. 9.1%).
P/E vs sector
19.4x
median 15.2x
ROE vs sector
16.3%
median 15.3%
Growth vs sector
12.3%
median 9.1%
Sector rank
#53
of 76 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Financials companies by sub-industry and size. Sector median is across all 76 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$63.19 – $109.14
vs. $227.09 today · expected CAGR -23% – -14%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $38.39B | $42.99B | $48.15B | $53.93B | $60.40B |
| Net income | $5.76B | $6.45B | $7.22B | $8.09B | $9.06B |
| EPS | $3.65 | $4.09 | $4.58 | $5.13 | $5.74 |
| Share price (low) | $40.16 | $44.98 | $50.37 | $56.42 | $63.19 |
| Share price (high) | $69.36 | $77.69 | $87.01 | $97.45 | $109.14 |
| CAGR (low–high) | -82% / -69% | -55% / -42% | -39% / -27% | -29% / -19% | -23% / -14% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for MS:
- Revenue is growing 12.3% a year, a sign of real demand.
- Strong return on equity (16.3%) shows capital is put to work well.
The case against MS:
- Elevated leverage (debt/equity 7.9x) adds financial risk.
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Balance-sheet risk — debt/equity of 7.9x magnifies the impact of higher rates or weaker earnings.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: Morgan Stanley is a mega-cap financials business still growing nicely, with solid profitability, and a heavier debt load to watch. It trades at 19.4x earnings, which our model scores Neutral (57/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.